Development of nanocrystal formulation of mebendazole with improved dissolution and pharmacokinetic behaviors

被引：0
|
作者：
Naofumi Hashimoto [1 ]
Kayo Yuminoki [1 ]
Haruka Takeuchi [1 ]
Chiaki Okada [1 ]
机构：
[1] Setsunan University
来源：
AsianJournalofPharmaceuticalSciences | 2016年 / 11卷 / 01期
关键词：
D O I：
暂无
中图分类号：
R943 [制剂学];
学科分类号：
100602 ; 100702 ;
摘要：
Nanosizing by wet beads milling is a method to improve the solubility of poorly water soluble compounds [1,2]. Mebendazole(MBZ) is a well-known anthelmintic drug in wide clinical use.There were some reports that MBZ had the anticancer effect in preclinical study. However, the bioavailability of MEB is low(<10%) due to the poor solubility in water (0.5μg/mL). The present study aimed to develop the nanocrystal formula-
引用
收藏
页码：122 / 123
页数：2
相关论文
共 50 条
  • [41] Albendazole Nanocrystal-Based Dissolving Microneedles with Improved Pharmacokinetic Performance for Enhanced Treatment of Cystic Echinococcosis
    Permana, Andi Dian
    Paredes, Alejandro J.
    Zanutto, Fabiana Volpe
    Amir, Muh Nur
    Ismail, Ismail
    Bahar, Muh Akbar
    Sumarheni
    Palma, Santiago Daniel
    Donnelly, Ryan F.
    ACS APPLIED MATERIALS & INTERFACES, 2021, 13 (32) : 38745 - 38760
  • [42] Nanocrystal-Loaded Lipid Carriers for Improved Oral Absorption and Anticancer Efficacy of Etoposide: Formulation Development, Transport Mechanism, In Vitro and In Vivo Evaluation
    Wang, Yue
    Wang, Ping
    Li, Haiyan
    Han, Xiaoran
    Zhu, Haibin
    Jin, Xiangqun
    MOLECULAR PHARMACEUTICS, 2024, 21 (03) : 1170 - 1181
  • [43] Formulation development and pharmacokinetic evaluation of enteric-coated dexrabeprazole tablets
    Lee, Tae Jin
    Kim, Dohyun
    Kim, Jae Cheon
    Ro, Si Won
    Dong Hee Na
    JOURNAL OF PHARMACEUTICAL INVESTIGATION, 2023, 53 (02) : 323 - 331
  • [44] Formulation development and pharmacokinetic evaluation of enteric-coated dexrabeprazole tablets
    Tae Jin Lee
    Dohyun Kim
    Jae Cheon Kim
    Si Won Ro
    Dong Hee Na
    Journal of Pharmaceutical Investigation, 2023, 53 : 323 - 331
  • [45] Nanocrystal Formulation to Enhance Oral Absorption of Silybin: Preparation, In Vitro Evaluations, and Pharmacokinetic Evaluations in Rats and Healthy Human Subjects
    Seo, SeungRee
    Kim, Gwan-Young
    Kim, Min-Hwan
    Lee, Kyung Won
    Kim, Min-Jae
    Chaudhary, Mansingh
    Bikram, Khadka
    Kim, Taeheon
    Choi, Seungmok
    Yang, Heejin
    Park, Joo Won
    Kim, Dae-Duk
    Kim, Ki-Taek
    PHARMACEUTICS, 2024, 16 (08)
  • [46] Formulation Development and Optimization of Rosuvastatin Loaded Nanosuspension for Enhancing Dissolution Rate
    Rani, Asha
    Verma, Ravinder
    Mittal, Vineet
    Bhatt, Shailendra
    Kumar, Manish
    Tiwari, Abhishek
    Tiwari, Varsha
    Pandey, Parijat
    Kaushik, Deepak
    CURRENT DRUG THERAPY, 2023, 18 (01) : 75 - 87
  • [47] Study of Formulation Development Based on the Pharmacokinetic Properties of Functional Food Components
    Sato, Yuki
    YAKUGAKU ZASSHI-JOURNAL OF THE PHARMACEUTICAL SOCIETY OF JAPAN, 2019, 139 (03): : 341 - 347
  • [48] Formulation Development and Dissolution Rate Enhancement of Efavirenz by Solid Dispersion Systems
    Koh, P. T.
    Chuah, J. N.
    Talekar, Meghna
    Gorajana, A.
    Garg, S.
    INDIAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2013, 75 (03) : 291 - 301
  • [49] Development of a Nanocrystal Formulation of a Low Melting Point API Following a Quality by Design Approach
    Ouranidis, Andreas
    Gkampelis, Nikos
    Markopoulou, Catherine
    Nikolakakis, Ioannis
    Kachrimanis, Kyriakos
    PROCESSES, 2021, 9 (06)
  • [50] Considerations in the development of an in vitro dissolution condition for lacidipine tablets: in vivo pharmacokinetic evaluation
    Sun, Mingyu
    Sun, Jin
    He, Shuangfeng
    Wang, Yongjun
    Sun, Yinghua
    Liu, Xiaohong
    He, Zhonggui
    DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY, 2012, 38 (09) : 1099 - 1106
12345